CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) DRUG UTILIZATION- AN ANALYSIS WITH THE RAMQ DATABASE

Author(s)

Lachaine J¹, Lapierre M¹, Lakhdari K²
¹University of Montreal, Montreal, QC, Canada, ²Novartis Pharmaceuticals Canada, Montreal, QC, Canada

Presentation Documents

PRS67--strong-u-lachaine-j-u-sup-1-sup-strong-lapierre-m-sup-1-sup-lakhdari-k-sup-2-sup-br-sup-1-sup-university-of-montreal-montreal-qc-canada-sup-2-sup-novartis-pharmaceuticals-canada-montreal-qc-canada

OBJECTIVES: The objectives of this study were to describe the COPD population and treatment patterns, to estimate treatment adherence, and to compare medication cost, in a real life setting, using the Régie de l’assurance maladie du Québec (RAMQ) database. METHODS: Patients who had a diagnosis of COPD (ICD-9 codes: 4910-4929, 4960-4969), or who received at least one script of a COPD medication from January 1^st

Conference/Value in Health Info

2014-05, ISPOR 2014, Palais des Congres de Montreal

Value in Health, Vol. 17, No. 3 (May 2014)

Code

PRS67

Topic

Health Service Delivery & Process of Care

Topic Subcategory

Prescribing Behavior, Treatment Patterns and Guidelines

Disease

Respiratory-Related Disorders

Presentation